| An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice | |
| Liu, Dong-qun1,2; Lu, Shuai1; Zhang, Ling-xiao1,2; Ji, Mei1,2; Liu, Shu-ying1; Wang, Shao-wei1; Liu, Rui-tian1 | |
| 2018-03-10 | |
| Source Publication | JOURNAL OF CONTROLLED RELEASE
 |
| ISSN | 0168-3659 |
| Volume | 273Pages:1-12 |
| Abstract | Therapeutic vaccine is a promising approach in cancer therapy. But tumor-associated antigen peptides have weak immunogenicity and cancer patients are often characterized by immunosuppression and tolerance, leading to less efficiency of immunotherapy. We here successfully developed indoleamine 2, 3-dioxygenase (IDO) siRNA nanoparticle-coated and tyrosinase-related protein 2 (Trp2)-displayed recombinant Saccharomyces cerevisiae (YCP). YCPs had positive charges with a diameter of approximately 5 mu m, resulting in selective phagocytosis by APC cells. YCP-delivered siRNA and Trp2 successfully escaped from phagosomes, efficiently inhibited IDO expression in DCs, promoted the immune reaction of T cell against Trp2, increased the secretion of proin-flammatory cytokines such as IFN-gamma, TNF-alpha, and IL-6, and decreased the generation of regulatory T cells. Moreover, YCPs significantly inhibited melanoma tumor growth by alleviating immune tolerance and promoting Trp2-specific CD8(+) T cell immune response. These results suggest that Saccharomyces cerevisiae as a combined immunotherapeutic platform to simultaneously delivery IDO-siRNA and Trp2 epitope peptide is a promising vaccine system for melanoma treatment. |
| Keyword | Small Interfering Rna (siRna) Indoleamine 2 Nanoparticle 3-dioxygenase (Ido) Tyrosinase-related Protein 2 (Trp2) Saccharomyces Cerevisiae Melanoma Tumor |
| Subtype | Article |
| WOS Headings | Science & Technology ; Physical Sciences ; Life Sciences & Biomedicine |
| DOI | 10.1016/j.jconrel.2018.01.013 |
| Indexed By | SCI |
| Language | 英语 |
| WOS Keyword | DENDRITIC CELL MATURATION ; SACCHAROMYCES-CEREVISIAE ; CANCER-IMMUNOTHERAPY ; TRYPTOPHAN CATABOLISM ; CROSS-PRESENTATION ; DNA COMPLEXES ; DELIVERY ; 2,3-DIOXYGENASE ; ANTIGEN ; TOLERANCE |
| WOS Research Area | Chemistry ; Pharmacology & Pharmacy |
| WOS Subject | Chemistry, Multidisciplinary ; Pharmacology & Pharmacy |
| Funding Organization | National Natural Science Foundation of China(81371208 ; National Science and Technology Major Projects of New Drugs(2014ZX09102045-005 ; State Key Laboratory of Biochemical Engineering(2015KF-02) ; 81402837 ; 2014ZX09102041-007) ; 31401158) |
| WOS ID | WOS:000426298100001 |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.ipe.ac.cn/handle/122111/24035 |
| Collection | 生化工程国家重点实验室 |
| Affiliation | 1.Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| Recommended Citation GB/T 7714 | Liu, Dong-qun,Lu, Shuai,Zhang, Ling-xiao,et al. An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice[J]. JOURNAL OF CONTROLLED RELEASE,2018,273:1-12. |
| APA | Liu, Dong-qun.,Lu, Shuai.,Zhang, Ling-xiao.,Ji, Mei.,Liu, Shu-ying.,...&Liu, Rui-tian.(2018).An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice.JOURNAL OF CONTROLLED RELEASE,273,1-12. |
| MLA | Liu, Dong-qun,et al."An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice".JOURNAL OF CONTROLLED RELEASE 273(2018):1-12. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment